Edoxaban

Results: 29



#Item
1Atrial Fibrillation (AFib) Treatment Adherence Following your treatment plan will reduce your risk of AFib-related stroke. it can enter the bloodstream and cause a stroke. A stroke means

Atrial Fibrillation (AFib) Treatment Adherence Following your treatment plan will reduce your risk of AFib-related stroke. it can enter the bloodstream and cause a stroke. A stroke means

Add to Reading List

Source URL: resources.hrsonline.org

Language: English - Date: 2015-09-09 14:29:44
2Press Release UK’s NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent deep vein thrombosis and pulmonary embolism in adults Tokyo, Japan (August 26, The National Insti

Press Release UK’s NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent deep vein thrombosis and pulmonary embolism in adults Tokyo, Japan (August 26, The National Insti

Add to Reading List

Source URL: www.daiichisankyo.com

Language: English - Date: 2016-01-03 23:45:25
    3Press Release UK’s NICE recommends once-daily LIXIANA® (edoxaban) for preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation Tokyo, Japan (September 23, The National Institut

    Press Release UK’s NICE recommends once-daily LIXIANA® (edoxaban) for preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation Tokyo, Japan (September 23, The National Institut

    Add to Reading List

    Source URL: www.daiichisankyo.com

    Language: English - Date: 2016-01-03 23:45:25
      4Press Release Daiichi Sankyo Europe GmbH ZielstattstrasseMunich · Germany Phone +

      Press Release Daiichi Sankyo Europe GmbH ZielstattstrasseMunich · Germany Phone +

      Add to Reading List

      Source URL: www.daiichi-sankyo.eu

      Language: English - Date: 2015-07-20 03:00:28
      52012 年度 Randomized, multicenter, warfarin-controlled phase II study of edoxaban in Japanese patients with non-valvular atrial fibrillation. Yamashita T, Koretsune Y, Yasaka M, Inoue H, Kawai Y, Yamaguchi T, Uchiyama

      2012 年度 Randomized, multicenter, warfarin-controlled phase II study of edoxaban in Japanese patients with non-valvular atrial fibrillation. Yamashita T, Koretsune Y, Yasaka M, Inoue H, Kawai Y, Yamaguchi T, Uchiyama

      Add to Reading List

      Source URL: www.cvi.or.jp

      Language: English - Date: 2015-03-31 20:17:57
      6A randomized, open-label trial of edoxaban in Japanese patients with severe renal impairment undergoing lower-limb orthopedic surgery

      A randomized, open-label trial of edoxaban in Japanese patients with severe renal impairment undergoing lower-limb orthopedic surgery

      Add to Reading List

      Source URL: www.thrombosisjournal.com

      Language: English
      7CONFIDENTIAL – DO NOT DISTRIBUTE Daiichi Sankyo’s Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention

      CONFIDENTIAL – DO NOT DISTRIBUTE Daiichi Sankyo’s Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention

      Add to Reading List

      Source URL: www.daiichisankyo.com

      Language: English - Date: 2015-04-15 00:50:32
      8整形外科学講座 1. 論文 (1) 原著 1) Kawaji H, Ishii M, Tamaki Y, Sasaki K, Takagi M: Edoxaban for prevention of venous thromboembolism

      整形外科学講座 1. 論文 (1) 原著 1) Kawaji H, Ishii M, Tamaki Y, Sasaki K, Takagi M: Edoxaban for prevention of venous thromboembolism

      Add to Reading List

      Source URL: www.yu-orthop.jp

      Language: English - Date: 2014-09-30 02:24:26
      9Press Release SAVAYSA™ (edoxaban) Now Available in U.S. Pharmacies Tokyo, Japan and Parsippany, NJ (February 9, 2015) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that SAVAYSA™ (edo

      Press Release SAVAYSA™ (edoxaban) Now Available in U.S. Pharmacies Tokyo, Japan and Parsippany, NJ (February 9, 2015) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that SAVAYSA™ (edo

      Add to Reading List

      Source URL: www.daiichisankyo.com

      Language: English - Date: 2015-02-08 18:45:08
      10SAVAYSA (edoxaban) tablets Label

      SAVAYSA (edoxaban) tablets Label

      Add to Reading List

      Source URL: www.accessdata.fda.gov

      Language: English - Date: 2015-01-08 17:30:22